KRYS – Krystal Biotech, Inc.
KRYS
$138.88Name : Krystal Biotech, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,013,451,520.00
EPSttm : 4.17
Krystal Biotech, Inc.
$138.88
Float Short %
12.23
Margin Of Safety %
43
Put/Call OI Ratio
1.26
EPS Next Q Diff
0.21
EPS Last/This Y
2.76
EPS This/Next Y
5.08
Price
138.96
Target Price
205.2
Analyst Recom
1.18
Performance Q
-24.01
Relative Volume
1.12
Beta
0.68
Ticker: KRYS
19 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | KRYS | 125.35 | 0.79 | 1.33 | 8595 |
2025-06-03 | KRYS | 131.04 | 0.79 | 0.96 | 8624 |
2025-06-04 | KRYS | 132.12 | 0.80 | 5.35 | 8819 |
2025-06-05 | KRYS | 132.82 | 0.99 | 0.99 | 9863 |
2025-06-06 | KRYS | 136.95 | 1.19 | 0.17 | 10872 |
2025-06-09 | KRYS | 136.08 | 1.19 | 0.03 | 10930 |
2025-06-10 | KRYS | 138.47 | 1.20 | 0.01 | 10922 |
2025-06-11 | KRYS | 139.73 | 1.20 | 0.02 | 10931 |
2025-06-12 | KRYS | 140.5 | 1.18 | 999.99 | 11051 |
2025-06-13 | KRYS | 137.16 | 1.18 | 0.01 | 11051 |
2025-06-16 | KRYS | 133.04 | 1.16 | 0.58 | 11160 |
2025-06-17 | KRYS | 130.02 | 1.16 | 0.07 | 11162 |
2025-06-18 | KRYS | 132.15 | 1.15 | 1.00 | 11170 |
2025-06-20 | KRYS | 132.51 | 1.15 | 0.58 | 11192 |
2025-06-23 | KRYS | 138.05 | 1.26 | 0.14 | 10245 |
2025-06-24 | KRYS | 143.7 | 1.26 | 0.37 | 10270 |
2025-06-25 | KRYS | 142.5 | 1.26 | 0.24 | 10285 |
2025-06-26 | KRYS | 142.69 | 1.26 | 0.00 | 10291 |
2025-06-27 | KRYS | 138.83 | 1.26 | 0.02 | 10291 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | KRYS | 125.22 | 35.2 | 77.4 | 5.88 |
2025-06-03 | KRYS | 130.91 | 35.2 | 90.1 | 5.88 |
2025-06-04 | KRYS | 132.11 | 35.2 | 81.2 | 5.88 |
2025-06-05 | KRYS | 132.62 | 35.2 | 79.9 | 5.88 |
2025-06-06 | KRYS | 136.81 | 35.2 | 86.6 | 5.88 |
2025-06-09 | KRYS | 136.08 | 35.2 | 77.3 | 5.88 |
2025-06-10 | KRYS | 138.30 | 35.2 | 82.9 | 5.88 |
2025-06-11 | KRYS | 139.67 | 35.2 | 81.5 | 5.88 |
2025-06-12 | KRYS | 140.33 | 35.2 | 80.1 | 5.88 |
2025-06-13 | KRYS | 137.10 | 35.2 | 73.1 | 5.88 |
2025-06-16 | KRYS | 133.06 | 35.2 | 71.5 | 5.88 |
2025-06-17 | KRYS | 130.09 | 35.2 | 73.2 | 5.88 |
2025-06-18 | KRYS | 132.09 | 35.2 | 82.9 | 5.88 |
2025-06-20 | KRYS | 132.46 | 35.2 | 79.5 | 5.88 |
2025-06-23 | KRYS | 138.02 | 35.2 | 89.4 | 5.88 |
2025-06-24 | KRYS | 143.91 | 35.2 | 89.7 | 5.88 |
2025-06-25 | KRYS | 142.46 | 35.2 | 76.7 | 5.88 |
2025-06-26 | KRYS | 142.57 | 35.2 | 79.0 | 5.88 |
2025-06-27 | KRYS | 138.96 | 35.2 | 72.5 | 5.88 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | KRYS | -4.68 | -1.27 | 10.48 |
2025-06-03 | KRYS | -4.68 | -1.27 | 10.48 |
2025-06-04 | KRYS | -4.68 | -1.27 | 10.48 |
2025-06-05 | KRYS | -4.68 | -1.27 | 10.48 |
2025-06-06 | KRYS | -4.68 | -1.27 | 10.48 |
2025-06-09 | KRYS | -4.68 | -1.28 | 10.48 |
2025-06-10 | KRYS | -4.68 | -1.28 | 10.48 |
2025-06-11 | KRYS | -4.68 | -1.28 | 11.77 |
2025-06-12 | KRYS | -4.68 | -1.28 | 11.77 |
2025-06-13 | KRYS | -4.68 | -1.28 | 11.77 |
2025-06-16 | KRYS | -2.41 | -1.30 | 11.77 |
2025-06-17 | KRYS | -2.41 | -1.30 | 11.77 |
2025-06-18 | KRYS | -2.41 | -1.30 | 11.77 |
2025-06-20 | KRYS | -2.41 | -1.30 | 11.77 |
2025-06-23 | KRYS | -2.41 | -1.33 | 11.77 |
2025-06-24 | KRYS | -2.41 | -1.33 | 11.77 |
2025-06-25 | KRYS | -2.41 | -1.33 | 11.77 |
2025-06-26 | KRYS | -2.41 | -1.33 | 12.23 |
2025-06-27 | KRYS | -2.41 | -1.33 | 12.23 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
1.2
Avg. EPS Est. Current Quarter
1.26
Avg. EPS Est. Next Quarter
1.41
Insider Transactions
-2.41
Institutional Transactions
-1.33
Beta
0.68
Average Sales Estimate Current Quarter
95
Average Sales Estimate Next Quarter
105
Fair Value
198.92
Quality Score
87
Growth Score
44
Sentiment Score
53
Actual DrawDown %
36.7
Max Drawdown 5-Year %
-53.4
Target Price
205.2
P/E
33.45
Forward P/E
15.93
PEG
0.54
P/S
12.04
P/B
4.08
P/Free Cash Flow
31.03
EPS
4.15
Average EPS Est. Cur. Y
5.88
EPS Next Y. (Est.)
10.95
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
37.18
Relative Volume
1.12
Return on Equity vs Sector %
-11.3
Return on Equity vs Industry %
6.5
EPS 1 7Days Diff
EPS 1 30Days Diff
-1.7
EBIT Estimation
72.5
Sector: Healthcare
Industry: Biotechnology
Employees: 275
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading